Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis.

Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis.
复制标题

DOI:
10.1002/pros.20805
复制
发表时间:
2008-09-15
期刊:
影响因子:
2.8
通讯作者:
Keller, Evan T.
Keller, Evan T.
中科院分区:
医学3区
文献类型:
--
作者:
Hall, Christopher L.;Daignault, Stephanie D.;Shah, Rajal B.;Pienta, Kenneth J.;Keller, Evan T.

文献摘要

参考文献

被引文献

相似文献

前列腺癌(PCa)经常转移到骨,并诱导成骨细胞病变。我们先前通过Wnt抑制剂dickkopf-1(DKK-1)的过表达证明,Wnt有助于体内PCa骨病变的成骨成分。为了检测DKK-1表达在PCa进展过程中的临床意义,通过免疫组织化学对组织微阵列进行DKK-1蛋白染色。发现PIN和原发性病变中的DKK-1表达指数(EI)与非肿瘤组织相比增加(分别为106±10 vs. 19±6,其中EI是表达百分比和染色强度的乘积)。还发现DKK-1表达在所有PCa转移性病变中(56±21 EI)高于非肿瘤组织,但与原发性PCa病变相比显著降低(p<0.008)。DKK-1的下降与β-连环蛋白染色从细胞核向细胞质的转移相关,这表明在PCa进展期间观察到的DKK-1水平下降的可能机制。在转移病灶内,除了淋巴结转移外,相对于所有软组织PCa转移病灶,DKK-1表达在PCa骨转移中最少。DKK-1在PCa转移灶中的高表达与患者总体生存期较短进一步相关。总之,这些数据表明,DKK-1表达升高是PCa的早期事件,并且随着PCa进展,DKK-1表达下降,特别是在晚期骨转移中。骨转移瘤中DKK-1的下降可以揭示Wnt的成骨活性。这些数据支持一个模型,其中DKK-1是一个分子开关,将前列腺癌骨病变的表型从溶骨性转变为成骨性。
Prostate cancer (PCa) frequently metastasizes to the bone and induces osteoblastic lesions. We previously demonstrated through over-expression of the Wnt inhibitor dickkopf-1 (DKK-1) that Wnts contribute to the osteoblastic component of PCa osseous lesions in vivo. To test the clinical significance of DKK-1 expression during PCa progression, tissue microarrays were stained for DKK-1 protein by immunohistochemistry. DKK-1 expression index (EI) was found to increase in PIN and primary lesions compared to non-neoplastic tissue (106±10 vs. 19±6, respectively, where the EI is the product of the percent expression and staining intensity). DKK-1 expression was also found to be higher in all PCa metastatic lesions (56±21 EI) compared to non-neoplastic tissues but was significantly decreased vs. primary PCa lesions (p<0.008). The decline in DKK-1 correlated with a shift of β-catenin staining from the nucleus to the cytoplasm suggesting possible mechanism for the observed decrease in DKK-1 levels during PCa progression. Within metastatic lesions, DKK-1 expression was least abundant in PCa bone metastases relative to all soft tissue PCa metastatic lesions except lymph node metastases. High DKK-1 expression within PCa metastases was further associated with shorter over-all patient survival. Taken together, these data demonstrate that elevated DKK-1 expression is an early event in PCa and that as PCa progresses DKK-1 expression declines, particularly in advanced bone metastases. The decline of DKK-1 in bone metastases can unmask Wnts’ osteoblastic activity. These data support a model in which DKK-1 is a molecular switch that transitions the phenotype of PCa osseous lesions from osteolytic to osteoblastic.
DOI: 10.1182/blood-2004-12-4940
发表时间: 2005-11-01
期刊: BLOOD
影响因子: 20.3
作者:
Oshima, T;Abe, M;Matsumoto, T
通讯作者: Matsumoto, T
DOI: 10.1158/0008-5472.can-05-1891
发表时间: 2005-09-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Dai, JL;Keller, J;Keller, ET
通讯作者: Keller, ET
DOI: 10.1126/science.281.5382.1509
发表时间: 1998-09-04
期刊: SCIENCE
影响因子: 56.9
作者:
He, TC;Sparks, AB;Kinzler, KW
通讯作者: Kinzler, KW
DOI: 10.1210/me.2003-0498
发表时间: 2004-05-01
影响因子: --
作者:
Bodine, PVN;Zhao, WG;Komm, BS
通讯作者: Komm, BS
DOI: 10.1038/sj.onc.1203783
发表时间: 2000-08-31
期刊: ONCOGENE
影响因子: 8
作者:
Roth, W;Wild-Bode, C;Weller, M
通讯作者: Weller, M